242 related articles for article (PubMed ID: 17136293)
1. New antihistamines: a critical view.
Camelo-Nunes IC
J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S173-80. PubMed ID: 17136293
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Devillier P; Roche N; Faisy C
Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
[TBL] [Abstract][Full Text] [Related]
3. Variations among non-sedating antihistamines: are there real differences?
Mattila MJ; Paakkari I
Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
[TBL] [Abstract][Full Text] [Related]
4. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
[TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
Mandhane SN; Shah JH; Bahekar PC; Mehetre SV; Pawar CA; Bagad AS; Chidrewar GU; Rao CT; Rajamannar T
Int Arch Allergy Immunol; 2010; 151(1):56-69. PubMed ID: 19672097
[TBL] [Abstract][Full Text] [Related]
6. [Clinical aspects of anti-inflammatory action of antihistamines].
Grzelewska-Rzymowska I
Pol Merkur Lekarski; 2003 Jun; 14(84):634-8. PubMed ID: 14524290
[TBL] [Abstract][Full Text] [Related]
7. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines.
Gillard M; Benedetti MS; Chatelain P; Baltes E
Inflamm Res; 2005 Sep; 54(9):367-9. PubMed ID: 16273334
[TBL] [Abstract][Full Text] [Related]
8. New oral H1 antihistamines in children: facts and unmeet needs.
de Benedictis FM; de Benedictis D; Canonica GW
Allergy; 2008 Oct; 63(10):1395-404. PubMed ID: 18782118
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic overview of oral second-generation H1 antihistamines.
González MA; Estes KS
Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
Delgado LF; Pferferman A; Solé D; Naspitz CK
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
[TBL] [Abstract][Full Text] [Related]
11. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
12. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
14. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
Soter NA
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011
[TBL] [Abstract][Full Text] [Related]
15. The second-generation antihistamines. What makes them different?
Ryhal BT; Fletcher MP
Postgrad Med; 1991 May; 89(6):87-8, 91-4, 99. PubMed ID: 1673571
[TBL] [Abstract][Full Text] [Related]
16. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects.
Kaliner MA
Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437
[TBL] [Abstract][Full Text] [Related]
17. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
18. Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.
Hey JA; Del Prado M; Cuss FM; Egan RW; Sherwood J; Lin CC; Kreutner W
Clin Exp Allergy; 1995 Oct; 25(10):974-84. PubMed ID: 8556569
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in H1-receptor antagonist treatment.
Simons FE
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):995-9. PubMed ID: 1979802
[TBL] [Abstract][Full Text] [Related]
20. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
